|
2015 Journal Article Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoproteinBista, Sudeep Raj, Haywood, Alison, Hardy, Janet, Lobb, Michael, Tapuni, Angela and Norris, Ross (2015). Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein. Xenobiotica, 45 (3), 207-212. doi: 10.3109/00498254.2014.971093 |
|
2015 Journal Article CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effectsLi, Yibai, Jackson, Kate A., Slon, Barry, Hardy, Janet R., Franco, Michael, William, Leeroy, Poon, Peter, Coller, Janet K, Hutchinson, Mark R, Currow, David C and Somogyi, Andrew A (2015). CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects. British Journal of Clinical Pharmacology, 80 (2), 276-284. doi: 10.1111/bcp.12614 |
|
2015 Journal Article Exposure to fentanyl after transdermal patch administration for cancer pain managementBista, Sudeep R., Haywood, Alison, Hardy, Janet, Norris, Ross and Hennig, Stefanie (2015). Exposure to fentanyl after transdermal patch administration for cancer pain management. Journal of Clinical Pharmacology, 56 (6), 705-713. doi: 10.1002/jcph.641 |
|
2014 Journal Article Therapeutic challenges in cancer pain management: a systematic review of methadoneGood, Phillip, Afsharimani, Banafsheh, Movva, Rayma, Haywood, Alison, Khan, Sohil and Hardy, Janet (2014). Therapeutic challenges in cancer pain management: a systematic review of methadone. Journal of Pain and Palliative Care Pharmacotherapy, 28 (3), 197-205. doi: 10.3109/15360288.2014.938883 |
|
2014 Journal Article Vitamin D deficiency in patients with malignancy in BrisbaneMorton, Adam, Hardy, Janet, Morton, Anthony, Tapuni, Angela, Anderson, Helen, Kingi, Ngaire and Shannon, Catherine (2014). Vitamin D deficiency in patients with malignancy in Brisbane. Supportive Care in Cancer, 22 (8), 2223-2227. doi: 10.1007/s00520-014-2218-z |
|
2014 Journal Article Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and salivaBista, S.R., Lobb, M., Haywood, A., Hardy, J., Tapuni, A. and Norris, R. (2014). Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 960, 27-33. doi: 10.1016/j.jchromb.2014.04.019 |
|
2014 Journal Article Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamineHardy, J. R., Spruyt, O., Quinn, S. J., Devilee, L. R. and Currow, D. C. (2014). Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine. Internal Medicine Journal, 44 (6), 586-591. doi: 10.1111/imj.12442 |
|
2014 Journal Article A good death in hospitalHardy, J. R. and Good, P. (2014). A good death in hospital. Internal Medicine Journal, 44 (4), 313-314. doi: 10.1111/imj.12378 |
|
2014 Journal Article Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of lifeMcCaffrey, Nikki, Skuza, Pawel, Breaden, Katrina, Eckermann, Simon, Hardy, Janet, Oaten, Sheila, Briffa, Michael and Currow, David (2014). Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life. PLoS One, 9 (4) e94316, e94316. doi: 10.1371/journal.pone.0094316 |
|
2014 Journal Article Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?Charles, Bruce, Hardy, Janet, Anderson, Helen, Tapuni, Angela, George, Rani and Norris, Ross (2014). Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?. Supportive Care in Cancer, 22 (2), 325-330. doi: 10.1007/s00520-013-1973-6 |
|
2013 Journal Article Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trialsNikles, Jane, Mitchell, Geoffrey K., Hardy, Janet, Agar, Meera, Senior, Hugh, Carmont, Sue-Ann, Schluter, Philip J., Good, Phillip, Vora, Rohan and Currow, David (2013). Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials. BMC Palliative Care, 12 (39) 39, 1-15. doi: 10.1186/1472-684X-12-39 |
|
2013 Journal Article Corticosteroids for the management of cancer-related pain in adults (Protocol)Hardy, Janet R., Jenkins-Marsh, Sue, Pinkerton, Eve, Rickett, Kirsty and Good, Phillip (2013). Corticosteroids for the management of cancer-related pain in adults (Protocol). Cochrane Database of Systematic Reviews, 2013 (10) CD010756. doi: 10.1002/14651858.CD010756 |
|
2013 Journal Article Ketamine in the management of cancer pain: reply to K. Jackson et al and W. LeppertHardy, Janet, Quinn, Steve, Fazekas, Belinda, Eckermann, Simon, Agar, Meera R., Spruyt, Odette, Rowett, Debra and Currow, David (2013). Ketamine in the management of cancer pain: reply to K. Jackson et al and W. Leppert. Journal of Clinical Oncology, 31 (10), 1375-1376. doi: 10.1200/JCO.2012.47.9469 |
|
2013 Journal Article Placebo and nocebo effects in randomized controlled trials: the implications for research and practiceSanderson, Christine, Hardy, Janet, Spruyt, Odette and Currow, David C. (2013). Placebo and nocebo effects in randomized controlled trials: the implications for research and practice. Journal of Pain and Symptom Management, 46 (5), 722-730. doi: 10.1016/j.jpainsymman.2012.12.005 |
|
2013 Journal Article Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocolSenior, Hugh E. J., Mitchell, Geoffrey K., Nikles, Jane, Carmont, Sue-Ann, Schluter, Philip J., Currow, David C., Vora, Rohan, Yelland, Michael J., Agar, Meera, Good, Phillip D. and Hardy, Janet R. (2013). Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol. BMC Palliative Care, 12 (1) 17, 17.1-17.6. doi: 10.1186/1472-684X-12-17 |
|
2013 Journal Article Can the LANSS scale be used to classify pain in chronic cancer pain trials?Hardy, Janet, Quinn, Stephen, Fazekas, Belinda, Aga, Meera and Currow, David (2013). Can the LANSS scale be used to classify pain in chronic cancer pain trials?. Supportive Care in Cancer, 21 (12), 3387-3391. doi: 10.1007/s00520-013-1921-5 |
|
2012 Journal Article Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies CollaborativeShelby-James, Tania M., Hardy, Janet, Agar, Meera, Yates, Patsy, Mitchell, Geoff, Sanderson, Christine, Luckett, Tim, Abernethy, Amy P. and Currow, David C. (2012). Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative. Palliative Medicine, 26 (8), 1042-1047. doi: 10.1177/0269216311417036 |
|
2012 Journal Article Management of type 2 diabetes mellitus in palliative care - is less more?Kindl, Korana, van Havre, Nathalie and Hardy, Janet (2012). Management of type 2 diabetes mellitus in palliative care - is less more?. European Journal of Palliative Care, 19 (6), 266-269. |
|
2012 Journal Article Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painHardy, Janet, Quinn, Stephen, Fazekas, Belinda, Plummer, John, Eckermann, Simon, Agar, Meera, Spruyt, Odette, Rowett, Debra and Currow, David C. (2012). Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. Journal of Clinical Oncology, 30 (29), 3611-3617. doi: 10.1200/JCO.2012.42.1081 |
|
2012 Journal Article Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?Hardy, Janet, Norris, Ross, Anderson, Helen, O'Shea, Angela and Charles, Bruce G. (2012). Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?. Supportive Care in Cancer, 20 (4), 767-772. doi: 10.1007/s00520-011-1147-3 |
